Inspire Medical Financials

INSP Stock  USD 196.61  11.76  6.36%   
Inspire Medical Systems is performing exceptionally good at this time. It has a great odds to report excellent financial results in March. At this time, Inspire Medical's Cash is relatively stable compared to the past year. As of 02/27/2025, Non Current Assets Total is likely to grow to about 186.5 M, while Other Liabilities is likely to drop slightly above 112.8 K. Key indicators impacting Inspire Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio6.757.1277
Notably Down
Slightly volatile
The financial analysis of Inspire Medical is a critical element in measuring its lifeblood. Investors should not minimize Inspire Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

56.18 Million

  
Understanding current and past Inspire Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Inspire Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Inspire Medical's assets may result in an increase in income on the income statement.

Inspire Medical Systems Earnings Geography

Inspire Medical Stock Summary

Inspire Medical competes with TransMedics, InMode, Insulet, Glaukos Corp, and Tandem Diabetes. Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and internationally. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Inspire Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 485 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS4577301090
CUSIP457730109
LocationMinnesota; U.S.A
Business Address5500 Wayzata Blvd,
SectorHealth Care Technology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.inspiresleep.com
Phone(844) 672 4357
CurrencyUSD - US Dollar

Inspire Medical Key Financial Ratios

Inspire Medical Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets281.2M295.1M564.9M676.8M808.4M848.8M
Other Current Liab13.5M20.1M33.0M39.3M48.2M50.6M
Net Tangible Assets139.8M229.7M229.0M496.0M570.4M598.9M
Net Debt(159.9M)(180.7M)(432.7M)(160.7M)(120.1M)(126.1M)
Retained Earnings(237.3M)(279.4M)(324.3M)(345.4M)(291.9M)(306.5M)
Accounts Payable7.2M11.7M26.8M38.8M38.7M40.6M
Cash190.5M214.5M441.6M185.5M150.2M161.1M
Long Term Debt24.9M24.5M24.7M15.8M18.2M21.8M
Net Receivables25.1M34.2M61.2M89.9M93.1M97.7M
Long Term Debt Total24.9M24.5M24.7M15.8M18.2M21.8M
Capital Surpluse319.9M467.0M508.5M820.3M943.4M990.6M
Inventory8.5M17.2M11.9M33.9M80.1M84.1M
Other Current Assets3.9M5.3M5.5M9.6M12.1M12.7M
Total Liab51.4M66.0M68.9M104.3M118.7M64.8M
Total Current Assets269.9M268.5M530.0M593.7M630.8M329.9M
Net Invested Capital254.5M254.0M496.0M572.5M689.7M362.7M
Net Working Capital249.1M227.2M468.8M515.6M542.3M324.8M

Inspire Medical Key Income Statement Accounts

The reason investors look at the income statement is to determine what Inspire Medical's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Interest Income1.1M125K5.1M18.1M23.2M24.4M
Interest Expense2.1M2.1M1.7M0.022K20.9K
Total Revenue115.4M233.4M407.9M624.8M802.8M842.9M
Gross Profit97.8M200.1M341.7M528.2M679.8M713.8M
Operating Income(56.2M)(39.9M)(47.6M)(40.3M)36.1M37.9M
Ebit(55.0M)(40.6M)(42.6M)(40.3M)58.5M61.4M
Research Development26.1M37.4M68.6M116.5M114.1M119.8M
Ebitda(53.2M)(38.6M)(39.7M)(40.3M)65.0M68.3M
Cost Of Revenue17.6M33.3M66.1M96.6M123.0M129.1M
Income Before Tax(57.1M)(42.0M)(44.3M)(19.9M)58.5M61.4M
Net Income(57.2M)(42.0M)(44.9M)(21.2M)53.5M56.2M
Income Tax Expense115K72K613K1.2M4.9M5.2M
Tax Provision115K72K613K895K4.9M5.2M
Net Interest Income(1.0M)(2.0M)3.4M18.1M23.2M24.4M

Inspire Medical Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(2.6M)(8.8M)5.3M(22.0M)(46.2M)(43.9M)
Investments89.1M33.8M(10.5M)(146.0M)(113.1M)(107.5M)
Change In Cash167.7M23.9M227.1M(256.1M)(35.4M)(33.6M)
Free Cash Flow(55.5M)(24.8M)2.5M1.0M91.1M95.7M
Depreciation840K1.2M1.9M2.8M6.6M6.9M
Other Non Cash Items1.4M1.4M812K1.3M(8.1M)(7.7M)
Capital Expenditures2.5M4.7M9.1M23.6M39.1M41.1M
Net Income(57.2M)(42.0M)(44.9M)(21.2M)53.5M56.2M
End Period Cash Flow190.5M214.5M441.6M185.5M150.2M146.3M
Change To Netincome6.1M12.7M26.2M51.4M59.1M62.1M
Change Receivables(6.5M)(11.8M)(9.2M)(27.0M)(24.3M)(23.1M)

Inspire Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Inspire Medical's current stock value. Our valuation model uses many indicators to compare Inspire Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inspire Medical competition to find correlations between indicators driving Inspire Medical's intrinsic value. More Info.
Inspire Medical Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.36  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Inspire Medical Systems is roughly  2.79 . At this time, Inspire Medical's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Inspire Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Inspire Medical Systems Systematic Risk

Inspire Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Inspire Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Inspire Medical Systems correlated with the market. If Beta is less than 0 Inspire Medical generally moves in the opposite direction as compared to the market. If Inspire Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Inspire Medical Systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Inspire Medical is generally in the same direction as the market. If Beta > 1 Inspire Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Inspire Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Inspire Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Inspire Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.31)

At this time, Inspire Medical's Price Earnings To Growth Ratio is relatively stable compared to the past year.

Inspire Medical February 27, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Inspire Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Inspire Medical Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Inspire Medical Systems based on widely used predictive technical indicators. In general, we focus on analyzing Inspire Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Inspire Medical's daily price indicators and compare them against related drivers.

Additional Tools for Inspire Stock Analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.